Cargando…
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial chemoembolization (TACE) is the first-line recommendation for intermediate-stage HCC. In real-world clinical practice, TACE also plays an im...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817054/ https://www.ncbi.nlm.nih.gov/pubmed/36643046 http://dx.doi.org/10.14218/JCTH.2022.00293 |
_version_ | 1784864676824219648 |
---|---|
author | Zhong, Bin-Yan Jin, Zhi-Cheng Chen, Jian-Jian Zhu, Hai-Dong Zhu, Xiao-Li |
author_facet | Zhong, Bin-Yan Jin, Zhi-Cheng Chen, Jian-Jian Zhu, Hai-Dong Zhu, Xiao-Li |
author_sort | Zhong, Bin-Yan |
collection | PubMed |
description | Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial chemoembolization (TACE) is the first-line recommendation for intermediate-stage HCC. In real-world clinical practice, TACE also plays an important role in early- and advanced-stage HCC. This review article by the experts from Chinese Liver Cancer Clinical Study Alliance (CHANCE) summarizes the available clinical evidence pertaining to the current application of TACE in patients with early-, intermediate-, and advanced-stage HCC. In addition, combination of TACE with other treatment modalities, especially immunotherapy, is reviewed. |
format | Online Article Text |
id | pubmed-9817054 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | XIA & HE Publishing Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98170542023-01-13 Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma Zhong, Bin-Yan Jin, Zhi-Cheng Chen, Jian-Jian Zhu, Hai-Dong Zhu, Xiao-Li J Clin Transl Hepatol Review Article Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial chemoembolization (TACE) is the first-line recommendation for intermediate-stage HCC. In real-world clinical practice, TACE also plays an important role in early- and advanced-stage HCC. This review article by the experts from Chinese Liver Cancer Clinical Study Alliance (CHANCE) summarizes the available clinical evidence pertaining to the current application of TACE in patients with early-, intermediate-, and advanced-stage HCC. In addition, combination of TACE with other treatment modalities, especially immunotherapy, is reviewed. XIA & HE Publishing Inc. 2023-04-28 2022-09-06 /pmc/articles/PMC9817054/ /pubmed/36643046 http://dx.doi.org/10.14218/JCTH.2022.00293 Text en © 2023 Authors. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Zhong, Bin-Yan Jin, Zhi-Cheng Chen, Jian-Jian Zhu, Hai-Dong Zhu, Xiao-Li Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma |
title | Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma |
title_full | Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma |
title_fullStr | Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma |
title_full_unstemmed | Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma |
title_short | Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma |
title_sort | role of transarterial chemoembolization in the treatment of hepatocellular carcinoma |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817054/ https://www.ncbi.nlm.nih.gov/pubmed/36643046 http://dx.doi.org/10.14218/JCTH.2022.00293 |
work_keys_str_mv | AT zhongbinyan roleoftransarterialchemoembolizationinthetreatmentofhepatocellularcarcinoma AT jinzhicheng roleoftransarterialchemoembolizationinthetreatmentofhepatocellularcarcinoma AT chenjianjian roleoftransarterialchemoembolizationinthetreatmentofhepatocellularcarcinoma AT zhuhaidong roleoftransarterialchemoembolizationinthetreatmentofhepatocellularcarcinoma AT zhuxiaoli roleoftransarterialchemoembolizationinthetreatmentofhepatocellularcarcinoma |